El1 also exhibited an antitumor effect only in SMARCB1-mutant rhabdoid tumors and EZH2-mutant diffuse large B cell lymphoma (DLBCL) [115]. This evidence concerns the gene EZH2 and diffuse large B-cell lymphoma.